Same Indication

Imatinib vs Levodopa

Imatinib vs Levodopa: Overview

This comparison examines the pharmacological differences between Imatinib and Levodopa.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Pharmacokinetics

Half-life: Imatinib β€” 18 hours; Levodopa β€” 1.5 hours.

Chemical Properties

Molecular Formula: Imatinib β€” C29H31N7O; Levodopa β€” C9H11NO4.

Molecular Weight: Imatinib β€” 493.6030 g/mol; Levodopa β€” 197.1880 g/mol.

Type: Imatinib β€” Small molecule; Levodopa β€” Small molecule.